The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women.

Publication Type:

Journal Article

Source:

Menopause (New York, N.Y.), Volume 17, Issue 3, p.622-9 (2010)

Keywords:

2010, Administration, Cutaneous, androgens, Center-Authored Paper, Estrogen Replacement Therapy, Estrogens, Estrogens, Conjugated (USP), Female, Humans, Medroxyprogesterone Acetate, Middle Aged, Postmenopause, Progesterone Congeners, Public Health Sciences Division, Reference Values, Sex Hormone-Binding Globulin, Shared Resources, Specimen Processing Core Facility

Abstract:

Differences in disease outcomes between users and nonusers of hormone therapy (HT) and between users of estrogen therapy (ET) and users of estrogen + progesterone therapy (EPT) may relate to differences in serum hormone concentrations between these populations. In this study, we examined the response of serum hormone levels in healthy postmenopausal women after 1 year of HT.